EP1166102A4 - CARDIAC ANOMALIES IN ANIMALS WITHOUT ENDOTHELIAL B VASCULAR GROWTH FACTOR (VEGF-B) AND METHODS RELATING TO THESE CARDIAC ABNORMALITIES - Google Patents

CARDIAC ANOMALIES IN ANIMALS WITHOUT ENDOTHELIAL B VASCULAR GROWTH FACTOR (VEGF-B) AND METHODS RELATING TO THESE CARDIAC ABNORMALITIES

Info

Publication number
EP1166102A4
EP1166102A4 EP00914803A EP00914803A EP1166102A4 EP 1166102 A4 EP1166102 A4 EP 1166102A4 EP 00914803 A EP00914803 A EP 00914803A EP 00914803 A EP00914803 A EP 00914803A EP 1166102 A4 EP1166102 A4 EP 1166102A4
Authority
EP
European Patent Office
Prior art keywords
cardiac
vegf
endothelial
animals
growth factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00914803A
Other languages
German (de)
French (fr)
Other versions
EP1166102A1 (en
Inventor
Karin Aase
Peter Thoren
Ulf Eriksson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Cancer Research filed Critical Ludwig Institute for Cancer Research Ltd
Publication of EP1166102A1 publication Critical patent/EP1166102A1/en
Publication of EP1166102A4 publication Critical patent/EP1166102A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0375—Animal model for cardiovascular diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP00914803A 1999-03-03 2000-03-03 CARDIAC ANOMALIES IN ANIMALS WITHOUT ENDOTHELIAL B VASCULAR GROWTH FACTOR (VEGF-B) AND METHODS RELATING TO THESE CARDIAC ABNORMALITIES Withdrawn EP1166102A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16008399P 1999-03-03 1999-03-03
US160083P 1999-03-03
PCT/US2000/005465 WO2000052462A1 (en) 1999-03-03 2000-03-03 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities

Publications (2)

Publication Number Publication Date
EP1166102A1 EP1166102A1 (en) 2002-01-02
EP1166102A4 true EP1166102A4 (en) 2002-08-21

Family

ID=22575449

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00914803A Withdrawn EP1166102A4 (en) 1999-03-03 2000-03-03 CARDIAC ANOMALIES IN ANIMALS WITHOUT ENDOTHELIAL B VASCULAR GROWTH FACTOR (VEGF-B) AND METHODS RELATING TO THESE CARDIAC ABNORMALITIES

Country Status (7)

Country Link
EP (1) EP1166102A4 (en)
JP (1) JP2004513328A (en)
CN (1) CN1342264A (en)
AU (1) AU3614700A (en)
CA (1) CA2363488A1 (en)
NZ (1) NZ513780A (en)
WO (1) WO2000052462A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709450B2 (en) 2001-06-20 2010-05-04 Ludwig Institute For Cancer Research Stimulation of vascularization with VEGF-B-186
EP2362942B1 (en) * 2008-10-30 2017-06-21 Luxembourg Institute of Health Biomarkers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026736A1 (en) * 1995-03-01 1996-09-06 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b
WO1998036052A1 (en) * 1997-02-18 1998-08-20 Ludwig Institute For Cancer Research Transgenic animal with recombinant vascular endothelial growth factor b (vegf-b) dna and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026736A1 (en) * 1995-03-01 1996-09-06 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b
WO1998036052A1 (en) * 1997-02-18 1998-08-20 Ludwig Institute For Cancer Research Transgenic animal with recombinant vascular endothelial growth factor b (vegf-b) dna and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KAWATA HIROYUKI ET AL: "Upregulation of VEGF-B mRNA in the rat heart following acute myocardial infarction (AMI).", JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, vol. 30, no. 6, June 1998 (1998-06-01), XVI World Congress of the International Society for Heart Research: Cardiovascular Biology and Medicine into the 21st Century, pages A43, XP008003746, ISSN: 0022-2828 *
See also references of WO0052462A1 *

Also Published As

Publication number Publication date
CN1342264A (en) 2002-03-27
AU3614700A (en) 2000-09-21
WO2000052462A1 (en) 2000-09-08
JP2004513328A (en) 2004-04-30
EP1166102A1 (en) 2002-01-02
CA2363488A1 (en) 2000-09-08
NZ513780A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
DE60043005D1 (en) PROSTHESIS IMPLANTABLE IN ONE LUMEN
ID26384A (en) DIAGNOSIS METHOD OF NUTRITIONAL CONDITIONS FROM HARVEST IN FLOOR PLANT
GB2355190B (en) Improvements in or relating to sterilising preparations
EP1072256A4 (en) QUICKLY DISINTEGRATED TABLETS IN ORAL CAVITY AND THEIR PRODUCTION METHOD
DE60111184D1 (en) ARTIFICIAL HEART FLAP
NO20004133L (en) Antibodies to human CD40
NO20003707D0 (en) Procedure for rich living with nutrients essential for fish larvae
FI972524A0 (en) Fungicides to control mustard disease in plants
ID28111A (en) METHODS TO IMPROVE SKIN HEALTH
FI19992070L (en) Novel fucosylated oligosaccharides and method for their preparation
AU6539000A (en) Composition and method for treating disease by increasing activated alpha2 macroglobulin in the blood and extravascular tissue
EP1166102A4 (en) CARDIAC ANOMALIES IN ANIMALS WITHOUT ENDOTHELIAL B VASCULAR GROWTH FACTOR (VEGF-B) AND METHODS RELATING TO THESE CARDIAC ABNORMALITIES
EP1244443A4 (en) METHOD FOR INCREASING THE CONCENTRATION OF ASCORBIC ACID IN THE CEREBRAL TISSUES OF A SUBJECT
EP1323425A4 (en) COMPOSITION FOR REDUCING NEUTRAL FAT IN BLOOD
DE59906721D1 (en) Device for harvesting stalk crops
NO20014848D0 (en) Method of using Emamectin in the treatment of fish parasites
GB9414103D0 (en) Improvements in or relating to fish farms
NO20020207D0 (en) Biological materials and methods useful in the diagnosis and treatment of disease
FI963947A7 (en) Fully dissolved bone tissue and method for preparing the same
PT1226837E (en) TOTAL ORTHOPEDIC ARTIFICIAL HEART
DE69933052D1 (en) HEART VALVE PROSTHESIS
IT1316921B1 (en) BIOARTIFICIAL ORGAN TO HOST ANIMAL AND / OR HUMAN CELLS.
DE69533075D1 (en) Baler and process to process the crop
AU7686400A (en) Ribozymes to growth factor originating in human platelet
FR2795920B3 (en) FOOD AND FORAGE

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010917

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020705

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020924